Disclosure Of Entity's Operating Segments [Text Block]

GENFLOW BIOSCIENCES PLC - Filing #1906463

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
2021-01-18 to
2021-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Tax expense (income)
- GBP
- GBP
Profit (loss) before tax
1,335,325 GBP
988,195 GBP
Profit (loss) from continuing operations
1,335,325 GBP
988,195 GBP
Profit (loss)
- GBP
1,335,321 GBP
- GBP
1,335,325 GBP
- GBP
1,335,325 GBP
- GBP
988,195 GBP
- GBP
988,195 GBP
- GBP
988,195 GBP
Assets
2,617,461 GBP
276,551 GBP
Liabilities
250,988 GBP
221,427 GBP
Cash flows from (used in) operating activities
1,368,324 GBP
747,377 GBP
Cash flows from (used in) investing activities
2,480 GBP
198,502 GBP
Cash flows from (used in) financing activities
3,499,516 GBP
783,711 GBP

Talk to a Data Expert

Have a question? We'll get back to you promptly.